Jennifer S. Temel, MD, on The Changing Conversation Around Prognostication
2016 Palliative Care in Oncology SymposiumJennifer S. Temel, MD, of Massachusetts General Hospital, discusses increasing prognostic uncertainty in light of targeted treatments and immunotherapies, and the difficulty predicting who will benefit.
Related Videos
Sriram Yennu, MD, on Patient Perception of Curability
Sriram Yennu, MD, of The University of Texas MD Anderson Cancer Center, discusses findings from a study of an international cohort of patients with advanced cancer who received pallia...
Scott A. Irwin, MD, PhD, on Dealing With Delirium
Scott A. Irwin, MD, PhD, of Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute, discusses delirium—its definition, prevalence, consequences, assessment, and management.
J. Nicholas Dionne-Odom, PhD, on Supporting Family Caregivers: The ENABLE Model
J. Nicholas Dionne-Odom, PhD, of the University of Alabama at Birmingham, discusses the “hidden” health-care workforce of family caregivers and what clinicians can do to help ease the...
Eric Roeland, MD: Expert Perspective on Palliative Care in Oncology Meeting Highlights
Eric Roeland, MD, of the University of California, San Diego, discusses the key papers presented at this year’s Palliative Care in Oncology Symposium.
James F. Cleary, MD, on Global Access to Opioids
James F. Cleary, MD, of the University of Wisconsin Carbone Cancer Center, talks about the many reasons that 80% of the world’s population lacks access to opioids, the mainstay of can...
